Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Epstein-Barr virus infection, Esophageal Neoplasms, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Tumor Virus Infections, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, diffuse large B-cell lymphoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal cancer, esophageal disorder, follicular lymphoma, head and neck squamous cell carcinoma, immune system disorder, immunoproliferative disorder, intestinal disorder, lung disorder, lung neoplasm, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin squamous cell carcinoma, squamous cell carcinoma, triple-negative breast carcinoma, viral infectious diseaseActive, not recruitingPhase 1 / Phase 22025-10-16NCT05565417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunitas Therapeutics1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 3000NashvilleUnited States1
Site 4060SarasotaUnited States1
Site 4100OrlandoUnited States1
Site 4500Oklahoma CityUnited States1
Site 5000DenverUnited States1
Site 9112FairfaxUnited States1
Site 9280PortlandUnited States1
Site 9384AustinUnited States1
Site 9618TucsonUnited States1